Flux Analysis of Cholesterol Biosynthesis In Vivo Reveals Multiple Tissue and Cell-Type Specific Pathways

This biochemistry study used stable isotope tracing to map cholesterol biosynthesis pathways across different tissues and cell types in living mice — discovering that the canonical textbook pathway does not match reality in most tissues.

The classical Kandutsch–Russell pathway, long taught as the primary route to cholesterol, was not the dominant pathway in any tissue studied. Instead, a modified pathway (MK-R) and the Bloch pathway showed tissue-specific, dynamically regulated flux that was not simply explained by expression of the key enzyme DHCR24 alone. The interdigitation and tissue specificity of these pathways was more complex than prior models suggested.

The clinical relevance is modest but real. Statins inhibit HMG-CoA reductase upstream of both major pathways, so this finding does not change statin prescribing. However, it has implications for understanding the pharmacology of drugs targeting later steps in cholesterol synthesis (like DHCR7 or DHCR24 inhibitors) and for interpreting off-target effects of cholesterol biosynthesis inhibition in specific tissues.

We rate the evidence limited for clinical cardiovascular practice. Important basic biochemistry for pharmacologists and researchers; the clinical translation for standard CAD prevention is indirect at best.